Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Technology That Automates Blood Smears to Help Labs Accurately Diagnose Bloodborne Diseases

By LabMedica International staff writers
Posted on 19 Jan 2022

A team of researchers have developed devices to automate blood smears that can consistently create high-quality smears equivalent to those created by human experts. More...

The device developed by researchers from Cambridge University (Cambridge, England), Bath University (Bath, UK), and the Ifakara Health Institute (Ifakara, Tanzania) removes one of the biggest bottlenecks preventing quick, reliable malaria diagnosis

One of the key steps in diagnosing or treating many bloodborne diseases is to perform a blood smear, where a drop of blood is spread across a microscope slide for analysis. It is critical the technician collecting the sample perform this smear correctly and consistently, but mistakes at this stage are easy to make and often result in useless samples. The researchers' primary focus is on diagnosis of malaria, a deadly disease that kills more than 400,000 people every year. Malaria is best diagnosed by analyzing blood smears through a microscope. While performing research for a previous study, they noticed many of these testing smears were of poor quality.

Their solution, the autohaem devices, solves this problem by automating the smearing process so every smear is correct and consistent. The devices come in two varieties, the autohaem smear and the autohaem smear+, the latter of which is fully automated with a motorized smearing mechanism. In tests, inexperienced technicians were able to use the device to produce expert-quality smears.

A key goal of the project was to make the autohaem devices accessible to as many people as possible. The researchers designed their devices to be easy to build, using readily available or 3D-printed components. Furthermore, all software and hardware are open-source and freely available. The next step for the researchers is to test out their design in real-world conditions.

"Creating blood smears is a laborious, repetitive task that requires an expert level of skill and manual dexterity," said researcher Samuel McDermott. "By using automated blood smearing machines, such as autohaem devices, technicians will be able to increase their throughput while maintaining a high enough quality for diagnosis."

Related Links:
Cambridge University 
Bath University 
Ifakara Health Institute 


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Rapid Molecular Testing Device
FlashDetect Flash10
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Early and effective screening for gestational diabetes mellitus is becoming increasingly important (Photo courtesy of Shutterstock)

First-Trimester Blood Test Accurately Predicts Gestational Diabetes

Gestational diabetes mellitus (GDM) affects many pregnancies and is typically detected midway through pregnancy, often too late to prevent complications. Women diagnosed late face increased risks such... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.